The mast cell function-associated antigen (MAFA) is a type II membranal glycoprotein expressed by rat mast cells and basophils. MAFA clustering by its specific monoclonal antibody, (mAb) G63, efficiently inhibits the FcvarepsilonRI induced secretory response of mucosal-type mast cells of the RBL-2H3 line, as well as bone marrow-derived mast cells. Here we present results which suggest that MAFA has also a capacity of modulating the cell cycle of the RBL-2H3 line. We found that MAFA clustering, by mAb G63 or by its F(ab')2 fragments, reduces the cell proliferation rate. Cell cycle analysis by flow cytometry revealed that the number of cells in sub-G phase is considerably higher for cells on which MAFA was clustered. Results of biochemical experiments established that MAFA clustering leads to a marked increase in the transient tyrosine phosphorylation of the adaptor protein p62(Dok) and the inositol phosphatase SHIP. Concomitantly, their respective binding to RasGAP and Shc was increased. Furthermore, the GTP binding protein Sos1 was found to dissociate from Shc upon MAFA clustering, suggesting that SHIP and Sos1 compete for Shc binding. We therefore suggest that MAFA has also a role in regulating RBL-2H3 cell proliferation rate by inhibiting RasGTP formation in the Ras signaling pathway.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-2478(02)00013-5DOI Listing

Publication Analysis

Top Keywords

mafa clustering
16
cell cycle
12
mast cells
12
mafa
9
mast cell
8
cell function-associated
8
function-associated antigen
8
antigen mafa
8
tyrosine phosphorylation
8
rbl-2h3 cell
8

Similar Publications

Background: The mAFA-II cluster randomised trial demonstrated the efficacy of a mobile health-technology implemented 'Atrial fibrillation Better Care' (ABC) pathway (mAFA intervention) for integrated care management of patients with AF.

Objective: To evaluate the effect of mAFA intervention across phenotypes of patients with AF.

Design: We conducted a latent-class analysis (LCA) according to eight variables, including age and comorbidities.

View Article and Find Full Text PDF

Generation and application of novel hES cell reporter lines for the differentiation and maturation of hPS cell-derived islet-like clusters.

Sci Rep

August 2024

Paul Langerhans Institute Dresden (PLID) of Helmholtz Center Munich at the University Clinic Carl Gustav Carus of TU Dresden, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

The significant advances in the differentiation of human pluripotent stem (hPS) cells into pancreatic endocrine cells, including functional β-cells, have been based on a detailed understanding of the underlying developmental mechanisms. However, the final differentiation steps, leading from endocrine progenitors to mono-hormonal and mature pancreatic endocrine cells, remain to be fully understood and this is reflected in the remaining shortcomings of the hPS cell-derived islet cells (SC-islet cells), which include a lack of β-cell maturation and variability among different cell lines. Additional signals and modifications of the final differentiation steps will have to be assessed in a combinatorial manner to address the remaining issues and appropriate reporter lines would be useful in this undertaking.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the roles of BRG1 and BRM ATPase subunits from the SWI/SNF chromatin remodeling complex in the development of endocrine cells, particularly beta cells, which are crucial for insulin production.
  • Researchers created genetically modified mice to analyze the impacts of removing BRG1 in endocrine progenitor cells and varying levels of BRM deficiency, assessing metabolic health and pancreatic islet function.
  • Findings showed that mice with BRG1 and BRM deficiencies faced severe glucose intolerance and reduced insulin secretion due to diminished islet and hormone-producing cell populations, alongside disrupted gene expression crucial for cell differentiation.
View Article and Find Full Text PDF

Background/aim: Type 1 diabetes mellitus (T1DM) is caused by the autoimmune-mediated destruction of insulin-producing cells (IPCs) and still has no effective cure. Better understanding of the molecular mechanisms involved in the differentiation of embryonic stem cells (ESCs) into IPCs may help us improve the therapeutic strategies for treating T1DM. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (Pfkfb1-4) are key regulators of glucose metabolism.

View Article and Find Full Text PDF

Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis.

Gut

February 2024

State Key Laboratory of Oncology in South China and Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Article Synopsis
  • - The study focuses on understanding how diverse cancer cells in primary colorectal cancer (CRC) lead to metastasis, particularly to the liver and ovary, which remain largely unexplored.
  • - Using advanced techniques like single-cell RNA sequencing and spatial transcriptomics, researchers identified a stem-like cell cluster that drives metastasis, with specific subpopulations targeting the liver or ovary.
  • - They found that interactions with surrounding cells and metabolic support from myofibroblasts are crucial for the cancer cells' ability to migrate and establish in the ovary, highlighting a new mechanism for organ-specific CRC metastasis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!